Assessing the long-term economic impact of cholinesterase inhibitor therapy in patients with Alzheimer's disease

被引：0
|
作者：
Caro, J [1 ]
Ward, A [1 ]
Salas, M [1 ]
Getsios, D [1 ]
Migliaccio-Walle, K [1 ]
Garfield, F [1 ]
机构：
[1] Caro Res Inst, Concord, MA USA
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
307
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [21] Long-term treatment with galantamine in patients with Alzheimer's disease and Alzheimer's disease with cerebrovascular disease
    Feldman, H
    Van Baelen, B
    Brashear, HR
    Schwalen, S
    Kavanagh, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S198 - S199
  • [22] Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease
    Hogan, David B.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (12): : 618 - 623
  • [23] Persistence of cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease
    Amuah, Joseph E.
    Hogan, David B.
    Eliasziw, Michael
    Supina, Alison
    Beck, Patricia
    Downey, Winnane
    Maxwell, Colleen J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S223 - S223
  • [24] Long-term donepezil treatment in patients with Alzheimer’s disease
    Andrew Kertesz
    Current Neurology and Neuroscience Reports, 2004, 4 (6) : 459 - 460
  • [25] Long-term tacrine treatment in patients with Alzheimer's disease
    Solomon, PR
    Knapp, MJ
    Gracon, SI
    Groccia, M
    Pendlebury, WW
    LANCET, 1996, 348 (9022): : 275 - 276
  • [26] Prediction Models for Assessing Long-Term Outcome in Alzheimer's Disease: A Review
    Wattmo, Carina
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2013, 28 (05): : 440 - 449
  • [27] Long-term effects of propentofylline in patients with Alzheimer's disease: Safety, efficacy, and impact on disease progression
    Rother, M
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S2 - S2
  • [28] Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands
    Caro, JJ
    Salas, M
    Ward, A
    Getsios, D
    Mehnert, A
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2002, 14 (02) : 84 - 89
  • [29] Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease
    Zhu, Carolyn W.
    Livote, Elayne E.
    Scarmeas, Nikolaos
    Albert, Marilyn
    Brandt, Jason
    Blacker, Deborah
    Sano, Mary
    Stern, Yaakov
    ALZHEIMERS & DEMENTIA, 2013, 9 (06) : 733 - 740
  • [30] Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease
    Giacobini, E
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 : S3 - S10
12345